Abstract:The co-existence of coronavirus disease 2019 (COVID-19) and seasonal influenza epidemics has become a potential threat to human health, particularly in China in the oncoming season. However, with the relaxation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic, the rebound extent of the influenza activities is still poorly understood. In this study, we constructed a susceptible-vaccinated-infectious-recovered-susceptible (SVIRS) model to simulate influenza transmission and calibrated it using influenza surveillance data from 2018 to 2022. We projected the influenza transmission over the next 3 years using the SVIRS model. We observed that, in epidemiological year 2021–2022, the reproduction numbers of influenza in southern and northern China were reduced by 64.0% and 34.5%, respectively, compared with those before the pandemic. The percentage of people susceptible to influenza virus increased by 138.6% and 57.3% in southern and northern China by October 1, 2022, respectively. After relaxing NPIs, the potential accumulation of susceptibility to influenza infection may lead to a large-scale influenza outbreak in the year 2022-2023, the scale of which may be affected by the intensity of the NPIs. And later relaxation of NPIs in the year 2023 would not lead to much larger rebound of influenza activities in the year 2023-2024. To control the influenza epidemic to the pre-pandemic level after relaxing NPIs, the influenza vaccination rates in southern and northern China should increase to 53.8% and 33.8%, respectively. Vaccination for influenza should be advocated to reduce the potential reemergence of the influenza epidemic in the next few years.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study was funded by grants from the National Natural Science Foundation of China (Grant No. 82003509, 82173577, 81672005), and the Natural Science Foundation of Zhejiang Province (Grant No. LQ20H260009).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors

Influenza Resurgence after Relaxation of Public Health and Social Measures, Hong Kong, 2023

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Influenza’s plummeting and future dynamics: the roles of mask wearing, mobility change and SARS-CoV-2 interference

Impact of early phase COVID-19 precautionary behaviors on seasonal influenza in Hong Kong: A time-series modeling approach

The Incoming Influenza Season — China, the United Kingdom, and the United States, 2021–2022

Influenza?s Plummeting During the COVID-19 Pandemic: the Roles of Mask-Wearing, Mobility Change, and SARS-CoV-2 Interference

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study

Disappearance and Re-Emergence of Influenza during the COVID-19 Pandemic: Association with Infection Control Measures

Quantifying the Rebound of Influenza Epidemics after Relaxing Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic in China

The Effects of Mask Wearing, Mobility Change and SARS-CoV-2 Interference on Seasonal Influenza in Northern China, Southern China, England, and the United States

An Intense Out-of-Season Rebound of Influenza Activity after the Relaxation of Coronavirus Disease 2019 Restrictions in Beijing, China.

Increased population susceptibility to seasonal influenza during the COVID‐19 pandemic in China and the United States

Indoor Environmental Factors Associated with Influenza Transmission in Mainland China Between February and April 2023

An intense out-of-season rebound of the influenza activity after the relaxation of COVID-19 restrictions in Beijing, China

Quantifying the Rebound of Influenza Epidemics after the Adjustment of Zero-Covid Policy in China.

Resurgence of influenza and enterovirus infections in Taiwan post-COVID-19: A nationwide surveillance study

Two Peaks of Seasonal Influenza Epidemics - China, 2023

Effects of Human Behavior Changes During the Coronavirus Disease 2019 (COVID-19) Pandemic on Influenza Spread in Hong Kong

Assessing the Impact of COVID-19 Interventions on Influenza-Like Illness in Beijing and Hong Kong: an Observational and Modeling Study

Combinational Recommendation of Vaccinations, Mask-Wearing, and Home-Quarantine to Control Influenza in Megacities: An Agent-Based Modeling Study With Large-Scale Trajectory Data

Forecasting of influenza activity and associated hospital admission burden and estimating the impact of COVID-19 pandemic on 2019/20 winter season in Hong Kong